ARCHIVES

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

Guest Editorial: Learning from the Power Morcellation Fiasco: Government Must Do More to Regulate Devices

September 12, 2014

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008